共 7 条
- [7] A multicenter, open-label, prospective, randomized, dose-ranging pharmacokinetic study of the anti-TNF-α antibody afelimomab in patients with sepsis syndrome[J] . James Gallagher,Charles Fisher,Bruce Sherman,Mark Munger,Bruce Meyers,Travis Ellison,Steven Fischkoff,William T. Barchuk,Leah Teoh,Raja Velagapudi.Intensive Care Medicine . 2001 (7)